Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for Thrombocytopenia in Low/Int-1 Risk MDS
NCT00614523Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2008
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by Amgen. Started Jul 2008; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00614523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614523.